CLINICAL_TRIALS
trial_result
· 2025-09-05
Clinical Trial Update: PRISM Neurofeedback Training for MDD Anhedonic Patients [NA]
Summary
The clinical trial evaluating PRISM neurofeedback training for patients with major depressive disorder and anhedonia has completed; sponsor GrayMatters Health L…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: GrayMatters Health Ltd. | Conditions: Depression, Anhedonia | NA | Status: COMPLETED